The case in summary: More parents are choosing to take their children out of the national childhood vaccination program to give them a broader vaccine against HPV, especially Gardasil 9. Experts believe that Gardasil 9, which covers several viruses that can cause cancer, should be available to everyone, not just those with knowledge of it. This year there is a new round of tenders, and the professional community wants Gardasil 9 to be offered instead of the current vaccine in the childhood vaccination programme. The summary is made by an AI service from OpenAi. The content is quality assured by news’s journalists before publication. – I want my child to have the best possible coverage with regard to HPV infection. That is why I choose to do it, says Per Bjørnstad from Hamar. His son has received two doses in the childhood vaccination program with the vaccine Cervarix. But like many other parents, the father wants to take his child out of the program so he can buy Gardasil 9, the most expensive vaccine, for his son. – I think you should have access to the best and what covers the most viruses, he says. Per Bjørnstad usually works at the Cancer Society and therefore knows well how Gardasil 9 is a better vaccine. He hopes the vaccine will be offered in the children’s vaccination programme. Photo: Viktoria Hellem-Hansen / news Bjørnstad usually works at the Cancer Society. He says he is therefore well aware of why the vaccine is better than the one offered today. The Gardasil 9 vaccine covers far more viruses that can lead to cancer, the experts believe: This is HPV and the vaccines The vaccine used in the Norwegian child vaccination program is called Cervarix and only protects against HPV16 and HPV18. Certain HPV types can cause genital warts. Cervarix does not protect against this, but Gardasil 9 does. That vaccine protects HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58. In Norway, 7th grade girls have been offered the HPV vaccine since 2009 Boys since 2018. Both boys and girls in birth cohorts from 2006 and later have been offered Cervarix, which protects against HPV 16 and 18. Until now, the focus has been on eradicating cervical cancer in Norway. HPV is a common virus that is easily transmitted through sexual contact. The vast majority of people get one or more infections during their lifetime. Condoms do not provide complete protection against HPV infection because the virus is also found on areas of skin in the abdomen that condoms do not cover. Condoms are important to use to protect against other sexually transmitted diseases. Most HPV infections go away on their own. There is no screening program for HPV-related cancers other than cervical cancer. Source: Helsenorge.no – It would have been nice if the information had been available to everyone, and not just to those who are familiar with it, where this is talked about a lot. More people drop the standard vaccine news has spoken to several parents who have taken their child out of the vaccination program and have given Gardasil 9 to the children, but there are few who want to come forward with this. Manager at the health center in Hamar, Ragnhild Elisabeth Eliassen, knows of ten cases where children have been taken out of the program in their area. Photo: Private – Most people choose to follow the nationally recommended childhood vaccination programme. Eliassen says that there may be more cases that they do not know about. Figures show that there is an increase in the purchase of the vaccine for children aged 10–14, which costs a total of NOK 5,000 for three doses: Don’t want differences – The professional community has for many years seen with concern that we use Cervarix in the children’s vaccination programme, says senior physician Andreas Hopland. He works in the cancer surgery department at Radiumhospitalet. Recently, he and the national experts in the treatment of HPV diseases sent a letter to call for a change in the choice of HPV vaccine in the children’s vaccination programme. – We are concerned that the children should be vaccinated as best and as widely as possible against HPV disease caused by the HPV virus, both precursors to cancer, cancer and other types of disease. Andreas Hopland is senior physician at the cancer surgery department at Radiumhospitalet. Photo: Privat The letter also states that they are concerned about socio-economic differences in Norway, because those who can afford to pay and know about the vaccine get the best protection. This year there is a new round of tenders, and the professional community wants the vaccine Gardasil 9 to be offered instead. This means that two or more vaccine providers are competing for which HPV vaccine will be used as part of the child vaccination program next year. This is what the head of the Norwegian Medicines Agency, Hallstein Husbyn, says in an e-mail. Read more of his answer here: What does tendering for the HPV vaccine mean? This is what unit manager at the Norwegian Medicines Agency, Hallstein Husbyn, says: – A separate specialist group decides which vaccines can participate in the competition, competition rules and criteria to be used to select a winner. – This type of tender helps to ensure that it is not too expensive for the state to offer effective treatments, and that more people can get a good offer. Norway has one of the best childhood vaccination programs in the world, and reaches many users. – Such tenders usually last for a limited period of two to four years, and it is of great importance for the vaccine suppliers to win these. This perhaps explains some of the great interest surrounding the next HPV tender. The rules for the tender will soon be ready, and can then be made public. Read more about responsibility for vaccines here. Getting a vaccine that doesn’t cover everything The Cervarix vaccine that is given today is a good vaccine, Hopland believes. He says the doctors are happy that it is given. – But Gardasil 9 is a better vaccine, which also covers several HPV viruses that cause cancer, with direct protection. He goes on to say that the vaccine has been approved in the USA and soon in Europe as a vaccine against cancer of the oral cavity, which means ear, nose and throat cancer. – It is the HPV cancer that is increasing the most in Norway and Europe. A fourfold increase has been seen there. While penile cancer has doubled, so has it. One of the HPV viruses that this vaccine covers, but not today’s vaccine, can cause RRP and genital warts, for example. – RRP is a disease that requires a lot of resources, especially for the children who are born with it, with a double-digit number of operations for them. It is a disease for which there is no treatment, but it can be prevented by vaccinating against it. What is the RRP that one can get from HPV 6 and 11? RRP (Recurrent respiratory papillomatosis) is a condition caused by HPV viruses 6 and 11. HPV is particularly prevalent in and around the glottis, which is already the narrowest part of the human airway. The route of infection can be via birth, mother or sexually transmitted. It can lead to loss of voice and can threaten the respiratory tract in infants, who often have a more violent form of infection than in adults. The treatment will be surgery, a treatment that only relieves symptoms as long as the infection is active, which can take several years. The number of operations necessary to achieve symptom control is often several dozen. Australia, which has the oldest HPV vaccine program in the world, has seen a rapid reduction in outbreaks. Today, RRP among newborns is a rare finding in Australia, according to this article. Source: Professional communities in Norway on HPV disease. Read more here. Hopland himself gets to refer the most difficult genital wart cases, where they have to provide quite extensive treatments and reconstructions of genital organs to the patients. Hoping for a political decision Hopland says the professional community wishes that the politicians and decision-making authorities know what they recommend and want for the children. Hopland hopes that there will be a political decision to have a vaccine that covers more broadly, both genital warts and RRP. – In the long term, this can mean that you save the economy by not needing treatment for these diseases when they disappear. It will also probably be possible to scale down the cervical program in the long term by providing wider HPV vaccine coverage. Have you had the HPV vaccine? Yes, I got the vaccine in a program. 😊 Yes, but I bought the vaccine myself. 💸 No, but I have children who have received the doses 👪 No, I have not had the vaccine 💉 Show result Published 09.07.2024, at 06.54
ttn-69
– Do you think you should have access to the best – news Innlandet – Local news, TV and radio
